HUP0000280A2 - Kutyaféle OB-fehérje összetételek és eljárások előállításukra - Google Patents

Kutyaféle OB-fehérje összetételek és eljárások előállításukra

Info

Publication number
HUP0000280A2
HUP0000280A2 HU0000280A HUP0000280A HUP0000280A2 HU P0000280 A2 HUP0000280 A2 HU P0000280A2 HU 0000280 A HU0000280 A HU 0000280A HU P0000280 A HUP0000280 A HU P0000280A HU P0000280 A2 HUP0000280 A2 HU P0000280A2
Authority
HU
Hungary
Prior art keywords
methods
canine
compositions
kütya
protein compositions
Prior art date
Application number
HU0000280A
Other languages
English (en)
Inventor
Natasha Hernday
Original Assignee
Amgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc. filed Critical Amgen Inc.
Publication of HUP0000280A2 publication Critical patent/HUP0000280A2/hu
Publication of HUP0000280A3 publication Critical patent/HUP0000280A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)

Abstract

A találmány tárgya kűtyaféle OB-fehérje, és az ezzel kapcsőlatősösszetételek és eljárásők. A kűtyaféle OB aminősavszekvenciái, azezzel összefüggő nűkleinsav szekvenciák, vektőrők, gazdasejtek, arekőm-bináns termelés eljárásai, az ide vőnatkőzó ellenanyagők és/vagydiagnősztikai összetételek, gyógyszerészeti összetételek éstranszgenikűs állatők szintén a találmány tárgyátképezik. ŕ
HU0000280A 1996-03-01 1997-02-28 Canine ob protein compositions and methods HUP0000280A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60940896A 1996-03-01 1996-03-01
PCT/US1997/003209 WO1997032022A2 (en) 1996-03-01 1997-02-28 Canine ob protein compositions and methods

Publications (2)

Publication Number Publication Date
HUP0000280A2 true HUP0000280A2 (hu) 2000-06-28
HUP0000280A3 HUP0000280A3 (en) 2002-09-30

Family

ID=24440686

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000280A HUP0000280A3 (en) 1996-03-01 1997-02-28 Canine ob protein compositions and methods

Country Status (10)

Country Link
US (1) US20020142456A1 (hu)
EP (1) EP0912739A2 (hu)
JP (1) JP2000513564A (hu)
KR (1) KR19990087392A (hu)
CN (1) CN1217023A (hu)
AU (1) AU2317397A (hu)
CA (1) CA2247503A1 (hu)
HU (1) HUP0000280A3 (hu)
IL (1) IL125933A0 (hu)
WO (1) WO1997032022A2 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6001816A (en) * 1996-06-20 1999-12-14 Merck & Co., Inc. Gene therapy for leptin deficiency
EP0954579A1 (en) * 1996-06-20 1999-11-10 Merck & Co., Inc. Gene therapy for obesity
EP0950417A3 (en) 1998-02-23 2000-02-23 Pfizer Products Inc. Treatment of skeletal disorders
AU3863699A (en) * 1998-04-20 1999-11-08 Mayo Foundation For Medical Education And Research Treatment of osteoporosis with leptin
SE9904424D0 (sv) * 1999-07-13 1999-12-03 Sahltech Ab Use of interleukin-6 in combination with leptin in treatment of obesity
CA2901928C (en) 2013-03-13 2017-10-10 Eli Lilly And Company Modified canine leptin polypeptides
US20180009869A1 (en) * 2016-07-08 2018-01-11 AskGene Pharma, Inc. Fusion Protein Comprising Leptin and Methods for Producing and Using the Same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
WO1996023517A1 (en) * 1995-01-31 1996-08-08 Eli Lilly And Company Anti-obesity proteins
CA2221824A1 (en) * 1995-05-26 1996-11-28 Eli Lilly And Company Rhesus ob protein and dna

Also Published As

Publication number Publication date
HUP0000280A3 (en) 2002-09-30
JP2000513564A (ja) 2000-10-17
US20020142456A1 (en) 2002-10-03
CA2247503A1 (en) 1997-09-04
CN1217023A (zh) 1999-05-19
KR19990087392A (ko) 1999-12-27
WO1997032022A2 (en) 1997-09-04
WO1997032022A3 (en) 1997-10-09
AU2317397A (en) 1997-09-16
EP0912739A2 (en) 1999-05-06
IL125933A0 (en) 1999-04-11

Similar Documents

Publication Publication Date Title
EA200600525A1 (ru) Еро-имитирующие миметичекие антитела человека с центральной шарнирной областью, композиции, способы и применения
CY1121353T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
ATE445704T1 (de) Expressionsvektor für tierische zellen
WO2004003147A3 (en) Cngh0004 polypeptides, antibodies, compositions, methods and uses
DE60139690D1 (de) Immunisierung gegen chlamydia pneumoniae
WO2005005604A3 (en) Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses
CY1109715T1 (el) IL-1β ΔΕΣΜΕΥΤΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ΚΑΙ ΘΡΑΥΣΜΑΤΑ ΑΥΤΩΝ
YU9403A (sh) Anti-dualna antitela integrina, kompozicije, postupci i primene
WO2002020569A3 (en) Mammalian genes; related reagents and methods
CY1105282T1 (el) Διαγνωση της κοιλιοκακης με τη χρηση ενος επιτοπιου της γλιαδινης
ATE300619T1 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
HUP0000280A2 (hu) Kutyaféle OB-fehérje összetételek és eljárások előállításukra
WO2003038041A3 (en) Il-4 mutein proteins, antibodies, compositions, methods and uses
WO2003057821A3 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
ATE265533T1 (de) Saeugetierchemokine
ATE449173T1 (de) 32144, eine humane fettsäureamid-hydrolase und deren verwendungen
WO2003082206A3 (en) Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses
DE60142356D1 (de) 18480 humane proteinkinasemoleküle und ihre verwendungen
SE9800504L (sv) Ny peptid, diagnostiskt reagens och kit för detektion av rickettsioser
ATE433489T1 (de) 16836, ein mitglied der humanen phospholipase c familie und seine verwendungen
WO2003063767A3 (en) Rsv proteins, antibodies, compositions, methods and uses
WO2004042363A3 (en) In vivo imaging of e2f-regulated bioluminescent proteins
ATE207536T1 (de) Nukleotid sequenzen und daraus abgleitete aminosäuresequenzen vom tumorgen int 6
ATE449842T1 (de) Anti-bambi antikörper oder rna zur diagnose und therapie bei dickdarm- oder leberkrebs
CA2351722A1 (en) Mast cell-specific signal transducer and cdna thereof

Legal Events

Date Code Title Description
FC4A Lapse of provisional application due to refusal